EU Panel Recommends Luxturna for Inherited Retinal Dystrophy EU Panel Recommends Luxturna for Inherited Retinal Dystrophy

The EMA ' s CHMP has recommended marketing authorization for voretigene neparvovec for inherited retinal dystrophy caused by RPE65 gene mutations in adults and children.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news